CoChat

An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Many disease processes in the brain are reflected in the protein composition of the cerebrospinal fluid (CSF). In addition to proteins, CSF also contains a large number of endogenous peptides whose potential as disease biomarkers largely remains to be explored. We have developed a novel workflow in which multiplex isobaric labeling is used for simultaneous quantification of endogenous CSF peptides and proteins by liquid chromatography coupled with mass spectrometry. After the labeling of CSF samples, endogenous peptides are separated from proteins by ultrafiltration. The proteins retained on the filters are trypsinized, and the tryptic peptides are collected separately. We evaluated this technique in a comparative pilot study of CSF peptide and protein profiles in eight patients with Alzheimer's disease (AD) and eight nondemented controls. We identified several differences between the AD and control group among endogenous peptides derived from proteins known to be associated with AD, including neurosecretory protein VGF (ratios AD/controls 0.45-0.81), integral membrane protein 2B (ratios AD/controls 0.72-0.84), and metallothionein-3 (ratios AD/controls 0.51-0.61). Analysis of tryptic peptides identified several proteins that were altered in the AD group, some of which have previously been reported as changed in AD, for example, VGF (ratio AD/controls 0.70).

Overview

Integrity signals

Registry

Crossref · 10.1021/pr501076j

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

Metadata

Authors
Hölttä, M., Minthon, L., Hansson, O., Holmén-Larsson, J., Pike, I., Ward, M., Kuhn, K., Rüetschi, U., Zetterberg, H., Blennow, K., & Gobom, J.
Affiliations
  • University of Gothenburg (SE)
  • Lund University (SE)
  • Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, 431 80 Mölndal, Sweden
  • Proteome Sciences (United Kingdom) (GB)
  • Proteome Science R&D GmbH&CoKG, 60438 Frankfurt am Main, Germany
  • National Hospital for Neurology and Neurosurgery (GB)
Corresponding author
Gobom, Johan
Venue
Journal of Proteome Research
Published
2014-12-22
Volume
14
Issue
2
Pages
654-663
ISSN
  • 1535-3893 (ISSN-L)
  • 1535-3907
OpenAlex
W2060631637
Cited by
100
References
35
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 11 · 2021: 7 · 2020: 10 · 2019: 13 · 2018: 9 · 2017: 17 · 2016: 5 · 2015: 5
FWCI
3.85
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Proteome Research (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Adlerbertska Stiftelserna
  • Stiftelserna Wilhelm och Martina Lundgrens
  • Knut och Alice Wallenbergs Stiftelse
  • Vetenskapsr?det (521-2011-4709)
  • Kungl och Hvitfeldtska Stiftelsens
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, cerebrospinal fluid, biomarkers, CSF proteomics, endogenous peptides, VGF, metallothionein-3, tryptic peptides
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Cerebrospinal Fluid Proteins, Female, Humans, Male, Middle Aged, Peptides, Biomarkers, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.